Navigation Links
Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
Date:5/25/2012

HONG KONG, May 25, 2012 /PRNewswire-Asia/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise ("CCV") in China's prescription market, announced that Roxatidine Acetate Hydrochloride for Injection ("Roxatidine"), Sihuan Pharmaceutical's first-to-market generic drug, recently passed on-site inspection for drug registration conducted by the Chinese State Food and Drug Administration ("SFDA"). Expecting to obtain approval for production in the next three months, the Company plans to launch the drug to the market in the second half of the year, with hospitals as its major target market. It will be manufactured by Beijing Sihuan Pharmaceutical Co., Ltd., a wholly-owned manufacturing subsidiary.

Roxatidine is the fourth generation H2 receptor antagonist. The drug is categorized into two formulations - oral and injectable. The oral form of the drug was first launched in Japan in 1986 and is mainly used for gastric and duodenal ulcers, zollinger-ellison syndrome, reflux esophagitis and gastritis. The injectable form of the drug, which debuted in Japan in, is mainly used for upper gastrointestinal bleeding and pre-anesthesia application. Currently, Roxatidine is widely used in various countries, including Korea, Germany, Italy, the Netherlands, Greece and South Africa.  

Compared with other H2 receptor antagonists, the Roxatidine contains higher selectivity for H2 receptors and features a stronger effect on acid suppression. In addition, it contains a protective mucosal effect that other H2 receptors do not have. Although the Roxatidine has similar therapeutic efficacy to Proton pump inhibitors, it is safer, more stable and more cost-effective. These outstanding advantages are a testament to Roxatidine's clinical value. As a result, Roxatidine has been the first-line drug used for upper gastrointe
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actavis First-To-Market with Generic Equivalents of Clobex® Shampoo and Clobex® Topical Lotion
2. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
3. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
4. Mylan Launches Generic Version of Viramune® Tablets
5. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
6. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
7. Mylan Launches Generic Version of Plavix® Tablets
8. Mylan Launches Generic Lipitor® in Five European Countries
9. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
10. Mylan Launches Generic Version of Zyprexa® Tablets
11. Watson Launches Generic FORTAMET(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... , April 28, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets patented products that ... diseases, today announced that it has received an order ... in the country who offer Medicare Advantage programs. This ... 15 insurance plans who are now customers of Semler. ...
(Date:4/28/2015)... , April 28, 2015  Olympus, a precision technology ... and surgical procedures, among other core businesses, announced today ... Brooklyn Park, MN. The new ... designed to position the company for continued long-term growth ... dedication ceremony took place on April 27 and was ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4
(Date:4/28/2015)... New and more complex medicines offer ... payers, pharmacists and patients. Now Specialty Pharmacy Times, ... with the National Association of Specialty Pharmacy (NASP), ... this developing field to better equip pharmacy businesses ... “This partnership creates a powerful platform for getting ...
(Date:4/28/2015)... Hellen Chen, who is a bestselling author and ... to a study conducted by Washington University, between ... has increased by 20% while the number of unfaithful husbands ... report released this year from the Journal of ... or both spouses admit to infidelity, either physical or emotional ...
(Date:4/28/2015)... Angeles, CA (PRWEB) April 28, 2015 ... is 2.9 out of 5, indicating a medium ... power means buyers and suppliers have equal power during ... of substitutes. Rather than purchasing a health insurance policy ... Cigna Corporation or Humana), buyers can choose to self-fund ...
(Date:4/28/2015)... Memphis, Tennessee (PRWEB) April 28, 2015 ... FDA-approved modular system for two-stage revision of infected ... REMEDY® Spacer is sterile-packaged as a pre-formed, pre-loaded ... elution to the infected joint space. Combined ... articulating surfaces, the REMEDY® spacer is approved for ...
(Date:4/28/2015)... Saint Louis, MO (PRWEB) April 28, 2015 ... May 6, 2015 from 5:00 to 8:00 pm at the ... 01880. More than 50 hospitals, clinics and groups with career ... will be represented. Attendees will enjoy free hors d’oeuvres and ... for PracticeMatch says “Boston is an ideal location ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3
... with mild cognitive impairment revealed that results from cognitive ... warning system for the subsequent development of Alzheimer,s disease. ... the study with mild cognitive impairment, those with low ... metabolism in particular brain regions, as detected through positron ...
... ... is, at Kirkland Uncorked a festival of art, style and taste July 17-19 in Marina Park. ... Kirkland, WA (Vocus) June 26, 2009 ... that is, at Kirkland Uncorked a festival of art, style and taste July 17-19 ...
... nearly two-decade effort to,treat people living with HIV ... the epidemic. Inexpensive generic medicines are a large,part ... and the Harvard,School of Public Health., Brazil did ... prompted pharmaceutical companies with exclusive drugs to,lower their ...
... N.C. Simulating medical scenarios helps medical students learn ... done by researchers at Wake Forest University School of ... Teacher , shows that medical students not only enjoy ... Michael T. Fitch, M.D., Ph.D., the senior author of ...
... Integrate Primary and Specialty Care to Improve the Quality ... of commentaries to understand health and healthcare, With the ... Annals of Family Medicine editor Kurt Stange, M.D., ... help make sense of the problems and opportunities we ...
... , DENVER, July 13 DaVita Inc. ... for those diagnosed with chronic kidney disease (CKD), today announced Mahesh Krishnan, ... for Research, effective July 13, 2009. , , ... DaVita Clinical Research is recognized as a leader in clinical trials for ...
Cached Medicine News:Health News:Memory test and PET scans detect early signs of Alzheimer's 2Health News:Memory test and PET scans detect early signs of Alzheimer's 3Health News:Drinking Wine Is Good For The "Heart" & Environment 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 3Health News:Simulating medical situations helps students learn, retain basic science concepts 2Health News:July/August 2009 Annals of Family Medicine tip sheet 2Health News:July/August 2009 Annals of Family Medicine tip sheet 3Health News:July/August 2009 Annals of Family Medicine tip sheet 4Health News:July/August 2009 Annals of Family Medicine tip sheet 5Health News:July/August 2009 Annals of Family Medicine tip sheet 6Health News:July/August 2009 Annals of Family Medicine tip sheet 7Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 2Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 3
QC HGB is an assayed quality control material for Hemocue analyzers. This control is a solution of stabilized human red cells and is available in 3 levels for monitoring analyzer performance at sever...
VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
... for every general surgery need. No matter ... the GO450/GO400 Omni-Flex™ General Retractor Systems give ... the best possible exposure in the simplest ... and the hinged extension arm, the GO450 ...
Specifically designed to address the requirements of spine specialists performing vertebroplasty or kyphoplasty procedures....
Medicine Products: